Gholami Shadi K, Tay Chee Sin, Lee Jessica M, Zagoren Eleanor, Maris Stephen A, Wong Jian Yao, Garza Amanda E, Caliskan Guzelce Ezgi, Pojoga Luminita H, Adler Gail K, Romero Jose R, Williams Gordon H
Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Faculty of Medicine and Health Sciences, UCSI University, Kuala Lumpur, Malaysia.
J Endocrinol. 2021 Nov 24;252(1):1-13. doi: 10.1530/JOE-21-0126.
Inconsistencies have been reported on the effect of sex on aldosterone (ALDO) levels leading to clinical confusion. The reasons for these inconsistencies are uncertain but include estrogen and/or its receptor modulating target gene responses to mineralocorticoid receptor activation and ALDO secretagogues' levels. This study's goal was to determine whether ALDO's biosynthesis also differed by sex. Two approaches were used. First, plasma renin activity and aldosterone were measured in rats. Both were significantly higher in males. Secondly, using rat zona glomerulosa (ZG) cells, we assessed three ex vivo areas: (1) activity/levels of early steps in ALDO's biosynthesis (StAR and CYP11A1); (2) activity/levels of a late step (CYP11B2); and (3) the status of the mineralocorticoid receptor (MR)-mediated, ultrashort feedback loop. Females had higher expression of CYP11A1 and StAR and increased CYP11A1 activity (increased pregnenolone/corticosterone levels) but did not differ in CYP11B2 expression or activity (ALDO levels). Activating the ZG's MR (thereby activating the ultrashort feedback loop) reduced CYP11B2's activity similarly in both sexes. Exvivo, these molecular effects were accompanied, in females, by lower ALDO basally but higher ALDO with angiotensin II stimulation. In conclusion, we documented that not only was there a sex-mediated difference in the activity of ALDO's biosynthesis but also these differences at the molecular level help explain the variable reports on ALDO's circulating levels. Basally, both in vivo and ex vivo, males had higher ALDO levels, likely secondary to higher ALDO secretagogue levels. However, in response to acute stimulation, ALDO levels are higher in females because of the greater levels and/or activity of their StAR/CYP11A1.
关于性别对醛固酮(ALDO)水平的影响已有不一致的报道,这导致了临床困惑。这些不一致的原因尚不确定,但包括雌激素和/或其受体调节靶基因对盐皮质激素受体激活和醛固酮分泌刺激物水平的反应。本研究的目的是确定醛固酮的生物合成是否也因性别而异。我们采用了两种方法。首先,测量大鼠的血浆肾素活性和醛固酮水平。两者在雄性大鼠中均显著更高。其次,使用大鼠肾小球带(ZG)细胞,我们评估了三个离体方面:(1)醛固酮生物合成早期步骤(StAR和CYP11A1) 的活性/水平;(2)后期步骤(CYP11B2)的活性/水平;以及(3)盐皮质激素受体(MR)介导的超短反馈回路的状态。雌性大鼠中CYP11A1和StAR的表达更高,CYP11A1活性增加(孕烯醇酮/皮质酮水平升高),但CYP11B2的表达或活性(醛固酮水平)没有差异。激活ZG的MR(从而激活超短反馈回路)在两性中同样降低了CYP11B2的活性。在离体实验中,这些分子效应在雌性大鼠中表现为基础醛固酮水平较低,但在血管紧张素II刺激下醛固酮水平较高。总之,我们证明不仅醛固酮生物合成的活性存在性别介导的差异,而且这些分子水平的差异有助于解释关于醛固酮循环水平的不同报道。在基础状态下,无论是在体内还是离体实验中,雄性大鼠的醛固酮水平更高,这可能是由于醛固酮分泌刺激物水平较高所致。然而,在急性刺激下,雌性大鼠的醛固酮水平更高,因为其StAR/CYP11A1的水平和/或活性更高。